LP
LGL Partners Portfolio holdings
AUM
$225M
This Quarter Return
+8.22%
1 Year Return
+14.87%
3 Year Return
+56.73%
5 Year Return
+86.98%
10 Year Return
–
AUM
$597M
AUM Growth
+$597M
(-18%)
Cap. Flow
-$159M
Cap. Flow
% of AUM
-26.59%
Top 10 Holdings %
Top 10 Hldgs %
79.33%
Holding
110
New
10
Increased
41
Reduced
31
Closed
7
Top Buys
| 1 |
Vanguard S&P 500 ETF
VOO
|
$171M |
| 2 |
Vanguard Total Bond Market
BND
|
$34.8M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
$24.4M |
| 4 |
iShares Core S&P Mid-Cap ETF
IJH
|
$19.1M |
| 5 |
GMO US Quality ETF
QLTY
|
$3.88M |
Top Sells
| 1 |
Schwab US Broad Market ETF
SCHB
|
$93.4M |
| 2 |
iShares Russell 3000 ETF
IWV
|
$81.4M |
| 3 |
Vanguard Value ETF
VTV
|
$76.8M |
| 4 |
iShares Core US Aggregate Bond ETF
AGG
|
$53.8M |
| 5 |
Vanguard Total Stock Market ETF
VTI
|
$50.4M |
Sector Composition
| 1 | Financials | 1.66% |
| 2 | Technology | 1.29% |
| 3 | Communication Services | 0.98% |
| 4 | Consumer Discretionary | 0.94% |
| 5 | Healthcare | 0.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SRG
101
Seritage Growth Properties
SRG
$207M
| $121K | 0.02% |
+12,500
| New | +$121K |
|
102
Cogent Biosciences
COGT
$1.69B
| $97.4K | 0.02% |
14,500
| – | – |
|
|
USBC
103
USBC, Inc.
USBC
$407M
| $26.6K | ﹤0.01% |
42,220
| – | – |
|
104
Biogen
BIIB
$19.4B
| – | – |
-870
| Closed | -$225K |
|
105
First Trust Dow Jones Internet Index Fund ETF
FDN
$7.2B
| – | – |
-8,054
| Closed | -$1.5M |
|
106
iShares Europe ETF
IEV
$2.31B
| – | – |
-4,746
| Closed | -$251K |
|
107
Riot Platforms
RIOT
$5.09B
| – | – |
-505
| Closed | -$7.81K |
|
108
SPDR Portfolio S&P 500 Growth ETF
SPYG
$40.4B
| – | – |
-511,735
| Closed | -$33.3M |
|
|
109
Vanguard Value ETF
VTV
$144B
| – | – |
-513,480
| Closed | -$76.8M |
|
110
Utilities Select Sector SPDR Fund
XLU
$20.9B
| – | – |
-3,232
| Closed | -$205K |
|